- Home
- AUPH vs PRLB Comparison
AUPH vs PRLB Comparison
Compare AUPH & PRLB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AUPH
- PRLB
- Stock Information
- Founded
- AUPH 1993
- PRLB 1999
- Country
- AUPH Canada
- PRLB United States
- Employees
- AUPH N/A
- PRLB N/A
- Industry
- AUPH Biotechnology: Pharmaceutical Preparations
- PRLB Metal Fabrications
- Sector
- AUPH Health Care
- PRLB Industrials
- Exchange
- AUPH Nasdaq
- PRLB Nasdaq
- Market Cap
- AUPH 999.8M
- PRLB 824.1M
- IPO Year
- AUPH 1999
- PRLB 2012
- Fundamental
- Price
- AUPH $8.09
- PRLB $33.80
- Analyst Decision
- AUPH Strong Buy
- PRLB Buy
- Analyst Count
- AUPH 2
- PRLB 4
- Target Price
- AUPH $11.50
- PRLB $43.67
- AVG Volume (30 Days)
- AUPH 1.3M
- PRLB 241.0K
- Earning Date
- AUPH 05-05-2025
- PRLB 05-02-2025
- Dividend Yield
- AUPH N/A
- PRLB N/A
- EPS Growth
- AUPH N/A
- PRLB 0.37
- EPS
- AUPH 0.04
- PRLB 0.66
- Revenue
- AUPH $235,133,000.00
- PRLB $500,890,000.00
- Revenue This Year
- AUPH $11.86
- PRLB $3.49
- Revenue Next Year
- AUPH $24.96
- PRLB $4.82
- P/E Ratio
- AUPH $197.25
- PRLB $51.38
- Revenue Growth
- AUPH 33.97
- PRLB N/A
- 52 Week Low
- AUPH $4.77
- PRLB $25.76
- 52 Week High
- AUPH $10.67
- PRLB $46.73
- Technical
- Relative Strength Index (RSI)
- AUPH 54.42
- PRLB 45.61
- Support Level
- AUPH $7.59
- PRLB $32.04
- Resistance Level
- AUPH $7.83
- PRLB $35.38
- Average True Range (ATR)
- AUPH 0.34
- PRLB 1.81
- MACD
- AUPH 0.04
- PRLB 0.15
- Stochastic Oscillator
- AUPH 84.90
- PRLB 67.47
About AUPH Aurinia Pharmaceuticals Inc
Aurinia Pharmaceuticals Inc is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. The company developed LUPKYNIS (voclosporin), the first FDA-approved oral therapy for the treatment of adult patients with active lupus nephritis. It is also developing AUR200, a dual inhibitor of B cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL), for the potential treatment of autoimmune diseases.
About PRLB Proto Labs Inc. Common stock
Proto Labs Inc is an on-demand manufacturer of custom parts for prototyping and short-run production. The company offers developers and engineers quick-turn production services to reduce the time to market. Proto Labs uses injection molding, computer numerical control machining, and 3-D printing to manufacture custom parts for its clients. The company services clients' needs for prototype solutions, parts for testing procedures, bridge production capabilities during disruptions in manufacturing processes, limited-quantity requests, and end-of-life production support. Geographically, a majority of the company's revenue is derived from the United States and the rest from Europe.